News

Syncom Formulations (India) Limited has fixed Wednesday, September 23, 2026, as the record date for determining the entitlement of members for a dividend of Rs 0.10 per equity share for the financial year 2025-26, subject to shareholder approval at the company’s 38th Annual General Meeting to be held on Wednesday, September 30, 2026, via video conferencing or other audio-visual means. Shareholders who wish to waive their dividend entitlement are requested to submit a completed form to the company or its registrar and transfer agent, Ankit Online, by September 26, 2026.

Syncom Formulations (India) will hold a meeting of the Board of Directors of the Company on 11 August 2026.

Net profit of Syncom Formulations (India) rose 42.28% to Rs 25.17 crore in the quarter ended March 2026 as against Rs 17.69 crore during the previous quarter ended March 2025. Sales declined 9.05% to Rs 135.41 crore in the quarter ended March 2026 as against Rs 148.88 crore during the previous quarter ended March 2025.For the full year,net profit rose 54.64% to Rs 76.44 crore in the year ended March 2026 as against Rs 49.43 crore during the previous year ended March 2025. Sales rose 5.20% to Rs 489.17 crore in the year ended March 2026 as against Rs 465.01 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales135.41148.88 -9 489.17465.01 5 OPM %16.2511.92 -15.8311.64 - PBDT36.1824.58 47 107.6170.70 52 PBT33.7023.29 45 101.0865.50 54 NP25.1717.69 42 76.4449.43 55 Powered by Capital Market - Live News

Net profit of Syncom Formulations (India) rose 40.40% to Rs 24.57 crore in the quarter ended March 2026 as against Rs 17.50 crore during the previous quarter ended March 2025. Sales declined 9.74% to Rs 134.00 crore in the quarter ended March 2026 as against Rs 148.46 crore during the previous quarter ended March 2025.For the full year,net profit rose 55.54% to Rs 76.01 crore in the year ended March 2026 as against Rs 48.87 crore during the previous year ended March 2025. Sales rose 5.12% to Rs 486.57 crore in the year ended March 2026 as against Rs 462.85 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales134.00148.46 -10 486.57462.85 5 OPM %16.0311.77 -15.8611.56 - PBDT35.3424.28 46 107.0169.83 53 PBT32.8622.99 43 100.4864.64 55 NP24.5717.50 40 76.0148.87 56 Powered by Capital Market - Live News

Syncom Formulations (India) will hold a meeting of the Board of Directors of the Company on 22 May 2026.